Literature DB >> 3769119

[Dengue 2 in eastern Senegal: serologic survey in simian and human populations. 1974-85].

J F Saluzzo, M Cornet, C Adam, M Eyraud, J P Digoutte.   

Abstract

After the previously reported isolations of dengue 2 virus in eastern Senegal in 1974 and 1981-1982, a retrospective serological study on simian and human populations was carried out in the same area. We investigated 1,095 simian sera collected at regular intervals between 1974 and 1984 from wild caught monkeys and 1,783 human sera from young children less than 11 years old collected during punctual surveys after the rainy season from 1976 to 1985. Sera were tested using HAI test, CF test and for someone's ELISA for specific IgM antibodies. Serological data from monkeys corroborated the virus isolations and demonstrated the existence of two epizootics in 1974-1975 and 1981-1982. No CF antibodies were detected in children sera up to 1981 epizootic when about 11% of tested sera showed a probable infection by dengue 2 virus, no clinical dengue infections were notified by the medical staff. After 1982, serological results showed that the virus maintained in the same area until 1985. The mechanism of the circulation of dengue 2 virus in eastern Senegal is discussed on the basis of these serological results.

Entities:  

Mesh:

Year:  1986        PMID: 3769119

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot Filiales


  24 in total

1.  Low specificity of an immunochromatographic serological assay for diagnosis of dengue Fever in travelers returning with malaria.

Authors:  Rémi N Charrel; Xavier de Lamballerie
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Sylvatic dengue viruses share the pathogenic potential of urban/endemic dengue viruses.

Authors:  Nikos Vasilakis; Jane Cardosa; Mawlouth Diallo; Amadou A Sall; Edward C Holmes; Kathryn A Hanley; Scott C Weaver; Javier Mota; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2010-04       Impact factor: 5.103

3.  Potential of ancestral sylvatic dengue-2 viruses to re-emerge.

Authors:  Nikos Vasilakis; Elisabeth J Shell; Eric B Fokam; Peter W Mason; Kathryn A Hanley; D Mark Estes; Scott C Weaver
Journal:  Virology       Date:  2006-10-02       Impact factor: 3.616

Review 4.  The global distribution of yellow fever and dengue.

Authors:  D J Rogers; A J Wilson; S I Hay; A J Graham
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

Review 5.  Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health.

Authors:  Nikos Vasilakis; Jane Cardosa; Kathryn A Hanley; Edward C Holmes; Scott C Weaver
Journal:  Nat Rev Microbiol       Date:  2011-06-13       Impact factor: 60.633

Review 6.  The dengue viruses.

Authors:  E A Henchal; J R Putnak
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

7.  Infection dynamics of sylvatic dengue virus in a natural primate host, the African Green Monkey.

Authors:  Kathryn A Hanley; Mathilde Guerbois; Tiffany F Kautz; Meredith Brown; Stephen S Whitehead; Scott C Weaver; Nikos Vasilakis; Preston A Marx
Journal:  Am J Trop Med Hyg       Date:  2014-08-04       Impact factor: 2.345

Review 8.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

9.  Density-dependent competitive suppression of sylvatic dengue virus by endemic dengue virus in cultured mosquito cells.

Authors:  Kim M Pepin; Kathryn A Hanley
Journal:  Vector Borne Zoonotic Dis       Date:  2008-12       Impact factor: 2.133

10.  Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999-2000: entomologic findings and epidemiologic considerations.

Authors:  Mawlouth Diallo; Yamar Ba; Amadou A Sall; Ousmane M Diop; Jacques A Ndione; Mireille Mondo; Lang Girault; Christian Mathiot
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.